Merck should follow GSK’s lead and commit to selling its potential Ebola vaccine at cost
July 31, 2015 at 11:35 AM EDT
Between disease names that few people have ever heard of and scientific jargon, it’s rare for the results of a drug trial to make for an easily understandable headline...
